Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00999102Phase 4Completed
Phase 4, randomised, double-blind trial of nebivolol in hypertension (HTN) (2 arms), sponsored by Weill Cornell Medicine. Primary endpoints: Multidimensional Assessment of Fatigue Questionnaire Global Fatigue Score at 8 weeks and Treadmill Exercise Time at 8 weeks. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00999102.